FDA Supports Proposals to Incentivize Domestic Drug Manufacturing

The FDA has proposed policies in the Trump administration's budget to encourage domestic pharmaceutical manufacturing and clinical trials, with Commissioner Marty Makary citing the need to counter China's dominance in early-stage drug development. Key proposals include making U.S. clinical trials easier to run and giving domestic generics manufacturers a one-month advantage over foreign companies in challenging brand drug patents. Separately, the TrumpRx website, which launched in February 2026 with 40 drugs and now offers over 61 medications, will add AbbVie and Genentech products, including Humira at an 86% discount for uninsured patients. The initiatives represent multiple policy levers the administration is deploying to reshore drug manufacturing to the United States.

FDA proposals to incentivize domestic drug manufacturing

• ▪The Trump administration has been using a variety of policy levers to try and bring drug manufacturing to the United States
• ▪FDA Commissioner Marty Makary stated the agency needs giant, big ideas to counter China's dominance in early-stage clinical development of drugs
• ▪The FDA proposed making it easier to run early-stage clinical trials in the United States
• ▪The U.S. Food and Drug Administration proposed policies aimed at encouraging domestic development and manufacturing of drugs in the president's budget
• ▪The FDA's budget justification includes a legislative proposal that would let domestic manufacturers of generic drugs challenge brand drug patents a month before foreign companies

TrumpRx website expansion and drug pricing discounts

• ▪Humira is used to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis
• ▪The TrumpRx website sold about 40 drugs when it went live in February 2026
• ▪AbbVie and Genentech will officially start selling their medicines on the TrumpRx website
• ▪AbbVie struck a deal with the Trump administration in January to cut the cost of certain medicines
• ▪TrumpRx prescription prices are only available to patients who are uninsured or whose insurance does not cover the medication and who must pay the full list price out of pocket
• ▪AbbVie will sell Humira on the TrumpRx website at an 86% discount
• ▪TrumpRx sells over 61 drugs at a lower price as of April 2026

Perspective of FDA Commissioner Marty Makary

• ▪Marty Makary believes giant, big ideas are necessary to address China's competitive advantage in drug development
• ▪The FDA under Marty Makary views early-stage clinical trial reforms as a strategic tool for reshoring pharmaceutical production

Perspective of Trump administration

• ▪The Trump administration negotiated deals with pharmaceutical companies like AbbVie to secure steep discounts for uninsured patients
• ▪The Trump administration's budget proposal treats domestic generics manufacturers as deserving preferential treatment over foreign competitors
• ▪The Trump administration views TrumpRx as a mechanism to demonstrate pharmaceutical industry cooperation with domestic policy goals

Perspective of Domestic pharmaceutical manufacturers

• ▪Domestic generics manufacturers would gain a one-month head start over foreign companies in challenging brand drug patents under the FDA's legislative proposal